The gut vascular barrier (GVB) is emerging as a key systemic regulator, linking the intestinal environment to distant organs through immune and metabolic signaling. Beyond its role in nutrient transport and immune surveillance, the GVB acts as a selective gateway, preventing the systemic dissemination of microbial products while facilitating immune balance. Disruption of the GVB contributes to inflammatory bowel diseases (IBD), colorectal cancer (CRC), and liver pathology, but recent insights reveal its pivotal role in gut-brain communication. GVB dysfunction can trigger neuroinflammation and central nervous system (CNS) disorders by allowing harmful microbial metabolites and pro-inflammatory molecules to reach systemic circulation, affecting the choroid plexus vascular barrier (PVB) and brain homeostasis. Key regulators, including plasmalemmal-vesicle-associated protein 1 (PV-1), adhesion molecules (ICAM-1, MAdCAM-1, VCAM-1), and Toll-like receptors (TLRs), govern GVB integrity, while microbial metabolites like short-chain fatty acids (SCFAs) and tryptophan derivatives modulate vascular permeability and immune responses. This review highlights the GVB as a central player in multi-organ health, emphasizing its influence on the gut-liver and gut-brain axes. Understanding the GVB’s systemic impact opens new therapeutic avenues to restore barrier function, mitigate systemic inflammation, and treat complex diseases, from metabolic disorders to neurodegenerative and neurodevelopmental conditions.